News
WXXWY
7.60
-2.31%
-0.18
Weekly Report: what happened at WXXWY last week (0601-0605)?
Weekly Report · 2d ago
Weekly Report: what happened at WXXWY last week (0525-0529)?
Weekly Report · 06/01 09:39
Weekly Report: what happened at WXXWY last week (0518-0522)?
Weekly Report · 05/25 09:40
Weekly Report: what happened at WXXWY last week (0511-0515)?
Weekly Report · 05/18 09:40
Weekly Report: what happened at WXXWY last week (0504-0508)?
Weekly Report · 05/11 09:39
Weekly Report: what happened at WXXWY last week (0427-0501)?
Weekly Report · 05/04 09:38
Weekly Report: what happened at WXXWY last week (0420-0424)?
Weekly Report · 04/27 09:39
Weekly Report: what happened at WXXWY last week (0413-0417)?
Weekly Report · 04/20 09:37
Whitehawk jumps as Citizens issues Outperform rating ahead of trial data
Seeking Alpha · 04/16 18:30
Weekly Report: what happened at WXXWY last week (0406-0410)?
Weekly Report · 04/13 09:39
Akari Therapeutics slides 21% despite WuXi XDC backing its drug program
Seeking Alpha · 04/06 15:09
Weekly Report: what happened at WXXWY last week (0330-0403)?
Weekly Report · 04/06 09:39
Weekly Report: what happened at WXXWY last week (0323-0327)?
Weekly Report · 03/30 09:39
Wuxi Biologics ADR Non-GAAP EPS of ¥1.33, revenue of ¥21.79M
Seeking Alpha · 03/24 12:18
Weekly Report: what happened at WXXWY last week (0316-0320)?
Weekly Report · 03/23 09:37
Weekly Report: what happened at WXXWY last week (0309-0313)?
Weekly Report · 03/16 09:37
Weekly Report: what happened at WXXWY last week (0302-0306)?
Weekly Report · 03/09 09:38
Weekly Report: what happened at WXXWY last week (0223-0227)?
Weekly Report · 03/02 09:38
Weekly Report: what happened at WXXWY last week (0216-0220)?
Weekly Report · 02/23 09:37
Weekly Report: what happened at WXXWY last week (0209-0213)?
Weekly Report · 02/16 09:37
More
Webull provides a variety of real-time WXXWY stock news. You can receive the latest news about Wuxi Biologics through multiple platforms. This information may help you make smarter investment decisions.
About WXXWY
WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.